Langerhans cell histiocytosis

Nada Krstovski


Langerhans cell histiocytosis is a rare disease in children, its initial presentation is variable, the clinical course, prognosis and survival are mostly unpredictable. LCH is a proliferative disorder where pathologic Langerhans cells accumulate in a variety of organs. Historically, the nomenclature regarding this entity has been confusing because the disease was subcategorized as eosinophilic granuloma, Hand-Schüller-Christian disease and Abt-LettererSiwe disease, simply based upon the different clinical manifestations. This nomenclature remains valuable and preserves the important historic perspective of these disorders. Currently, LCH can be divided according to disease extent and localisation of the disease at the time of evaluation. The following clinical categories have been defined: single- or multi-system disease. This article summarizes the classification, history, pathophysiology, diagnostic criteria, different clinical manifestations, treatment, prognosis and long-term sequelae of LCH in children.


Histiocytosis; Children; Langerhans cell histiocytosis; Pediatric oncology

Full Text:




  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The full text of articles published in this journal can be used free of charge for personal and educational purposes while respecting authors and publishers' copyrights. For commercial purposes no part of this journal may be reproduced without the written permission of the publisher.